trial · primary record
Talquetamab
Hematological Malignancies
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 510 |
| Primary completion | 2029-03-30 |
| Primary endpoint | Overall Response Rate (ORR) |
| Registry ID | NCT04634552 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:37.511Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04634552
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Talquetamab · compound